20. 副腎白質ジストロフィー Adrenoleukodystrophy Clinical trials / Disease details

臨床試験数 : 61 / 薬物数 : 90 - (DrugBank : 31) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 126

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03864523 (ClinicalTrials.gov)	January 2016	16/9/2016	Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy	Effect of PioglitazoneAdministered to Patients With Adrenomyeloneuropathy: a Phase II, Single-arm, M ...	Adrenomyeloneuropathy;X-linked Adrenoleukodystrophy	Drug: Pioglitazone	Onofre, Aurora Pujol, M.D.	Instituto de Salud Carlos III;Fundacion Hesperia;ELA España Association	Completed	18 Years	65 Years	All	18	Phase 2	Spain
2	EUCTR2011-006113-34-ES (EUCTR)	24/10/2013	12/09/2013	Effect of pioglitazone in patienst with Adrenomyeloneuropathy.	Effect of pioglitazoneadministred to patients with Adrenomyeloneuropathy: A phase II, Singlearm, Mon ...	X-linked adrenoleukodystrophy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	INN or Proposed INN: PIOGLITAZONE	AURORA PUJOL ONOFRE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Spain

First Previous1Next Last